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Introduction
In a series of studies focused on developing artificial scaf-
folding for bone tissue engineering, our group has developed 
artificial scaffolds and culture conditions adequate to begin 
translational studies aimed at clinical use in reconstruction of 
bone defects.1 However, the ability to create a functional vas-
culature in bioengineered tissue is an unresolved challenge in 
regenerative medicine.2–4 In particular, developing an ade-
quate supply of oxygen and nutrients to cells within artificial 
scaffolds limits the size of defects for which tissue engineer-
ing might be a realistic treatment option. In vitro prevascu-
larization, where a vascular bed is developed before 
constructs are used in reconstructive surgery, has been pro-
posed as a way to overcome this obstacle.2
By combining individual vessel components such as 
endothelial cells (ECs), vascular smooth muscle cells 
(vSMCs), and basement membrane proteins, several 
authors have been able to construct a functional vasculature 
in vivo.5–7 Perivascular mural cells have been shown to 
regulate proliferation of ECs and promote vascular matura-
tion during the development of functional blood vessels.8 In 
order for newly developed blood vessel systems to main-
tain size, function, and cell survival, endothelial/mural   
cell connections and subsequent production of basement 
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membrane proteins are needed.8–10 The vascular endothelial 
growth factor (VEGF) and angiopoietin ligand/receptor 
systems include the most important signaling molecules in 
development and regulation of blood vessels.11 Bone mar-
row–derived mesenchymal stem cells (MSCs) have shown 
the ability to support vascular development in the presence 
of a collagen–fibronectin gel,12 and to stimulate vascular 
ingrowth into collagen sponges.13 Differentiation of MSC 
into vascular cells depends on signals provided by the local 
environment, in particular the extracellular matrix pro-
duced by ECs.14 In addition, the influence of ECs on osteo-
genic differentiation of MSC has been recognized by 
several authors.15–17
Despite extensive efforts to understand coculture sys-
tems in general, limited attempts have been made to clarify 
ideal culture conditions for prevascularization of tissue-
engineered bone. As pointed out by Ma et al.,18 the majority 
of coculture studies have focused on osteogenesis or angio-
genesis. However, in order to develop prevascularized bone 
constructs, culture conditions must support both the forma-
tion of functional vessels and osteogenesis. The aim of the 
current study was therefore to examine the mechanisms and 
the functional formation of endothelial microvascular net-
works in cocultures of primary human MSC and human 
umbilical vein ECs. Culture medium enriched with dexa-
methasone, ascorbic acid, and β-glycerophosphate (DAG) 
is an established method for inducing osteogenic differen-
tiation of MSC.19 We hypothesized that this osteogenic 
stimulatory medium (OM) would support formation and 
stabilization of endothelial networks, in addition to osteo-
genic differentiation and mineralization. Our results show 
the ability of OM to stimulate endothelial microvascular 
network development, and to support perivascular and 
osteogenic differentiation of MSC.
Materials and methods
Cells
Human umbilical vein ECs were purchased from Lonza 
(Clonetics®, Walkersville, MD) and expanded in Endothelial 
Cell Growth Medium 2 (EGM-2®) (Lonza). Primary human 
bone marrow–derived MSCs were purchased from 
StemCell Technologies (Vancouver, BC) and expanded in 
MesenCult® (MC) complete medium (StemCell 
Technologies). Flow cytometry was performed to assess 
purity of MSC, and >90% of the cells expressed CD29, 
CD44, CD105, and CD166, while <1% of the cells 
expressed CD14, CD34, and CD45. Cells from passages 
2–6 were used. All cells were cultured at 37°C in a humid 
atmosphere containing 5% CO2.
Organotypic blood vessel assay
ECs used for live fluorescence imaging were infected with 
retrovirus carrying a green fluorescent protein (GFP)–
expressing construct at an early passage, a procedure 
described previously.5,20 An in vitro organotypic blood ves-
sel system was used,21 with MSC used in this study as sup-
porting cells. Briefly, 25,000 MSCs and 5000 ECs were 
seeded in a half-area 96-well microplate and allowed to 
form capillary-like networks. The first live fluorescence 
imaging was made after 72 h. One-fourth of the culture 
medium was changed for all groups every second day until 
cells were fixed in 4% paraformaldehyde (PFA) after 15 
days. Cells were cultured in EGM-2, MC, OM, and EGM + 
OM (Table 1). Automated high-throughput imaging was 
performed to analyze the EC/MSC coculture assay on a BD 
Pathway 855 bioimaging system (BD Bioscences, San 
Jose, CA). The 2 × 2 montages of each well were acquired 
with a 10× lens. Noise reduction (rolling ball) and adjust-
ment of image threshold were performed with AttoVision 
v1.6.1 software (BD Bioscences). The threshold for mini-
mum segment size in the networks was set to 5000 pixels.
Coculture of MSC/EC
To evaluate EC gene expression, EC and MSC were cul-
tured in six-well plates (NUNC, Roskilde, Denmark) at a 
ratio of 5:1 (105 and 2 × 104 cells, respectively) or EC alone 
(105 cells) under the same conditions for 3 days. EGM-2 
culture medium was used. After 3 days, cells were 
Table 1.  Media used for coculture experiments
Full name Abbreviation Supplements
Endothelial growth medium-2 EGM 10% FBS, 0.1% hEGF, 0.1% hydrocortisone, and 0.1%  
GA-1000 
MesenCult MC MesenCult mesenchymal stem cell stimulatory supplements
Osteogenic medium OM 15% MesenCult osteogenic stimulatory supplements
  50 µg/mL ascorbic acid
  10−8 M dexamethasone
  3.5 mM β-glycerophosphate
Endothelial growth medium-2 +  
osteogenic medium
EGM + OM As for EGM < 7 days and OM > 7 days
FBS: fetal bovine serum; hEGF: human epidermal growth factor.Pedersen et al.  3
trypsinized, and positive isolation of EC was performed 
with CD31 Endothelial Cell Dynabeads® (Invitrogen, 
Carlsbad, CA) according to the manufacturer’s instruc-
tions. To evaluate the expression of VEGFa, indirect cocul-
ture was performed with cell culture inserts (NUNC) at a 
pore size of 3 µm. ECs were centrifuged and frozen in liq-
uid nitrogen before RNA isolation.
To evaluate stem cell differentiation, MSCs were cocul-
tured with EC in six-well plates at a ratio of 5:1 (105 and 2 
× 104 cells, respectively) or MSC alone (105 cells) under 
the same conditions for 15 days. Cells were cultured in the 
following culture media: EGM-2 (Lonza), osteogenic 
medium (OM) (StemCell Technologies), and EGM + OM 
(Table 1). Culture media were changed every 3 days. After 
15 days, cells were trypsinized and EC depleted with CD31 
Endothelial Cell Dynabeads according to the manufactur-
er’s instructions. MSCs were centrifuged and frozen in liq-
uid nitrogen before RNA isolation.
Real-time reverse transcriptase polymerase 
chain reaction
RNA was isolated and real-time reverse transcription–pol-
ymerase chain reaction (RT-PCR) was performed as previ-
ously described.22 At 3 days, Taqman® gene expression 
assays (Applied Biosystems™) were used to detect mRNA 
levels of glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), angiopoietin 1 (Ang1), angiopoietin 2 (Ang2), 
von Willebrand factor (vWF), and VEGFa from EC. Assays 
for GAPDH, SM22-α, and α-smooth muscle actin (α-
SMA) were used to detect mRNA levels in MSC after 15 
days of culture in OM. The data were analyzed with a com-
parative Ct method, where expression levels of the genes 
were normalized to the HouseKeeper index and GAPDH 
served as endogenous control.
Histological staining
Extracellular matrix staining of collagen IV was performed 
on fixed cocultures.21 Briefly, monoclonal mouse anticol-
lagen IV antibody (Millipore, Billerica, MA) diluted 1:200 
in phosphate-buffered saline (PBS)/2% fetal bovine serum 
(FBS) and Alexa546-conjugated goat antimouse IgG   
secondary antibody diluted 1:3000 in PBS/2% FBS 
(Invitrogen) were used. Images were acquired with a Zeiss 
LSM 510 Meta confocal microscope (Carl Zeiss, 
Oberkocken, Germany). To identify calcium, alizarin red S 
staining was performed. Two percent of alizarin red S 
powder (Sigma-Aldrich, St. Louis, MO) was dissolved in 
distilled water, and pH was adjusted to 4.2 with 0.5% 
ammonium hydroxide. Cocultures were stained for 3 min 
and imaged with a Nikon TS100 microscope (Nikon, 
Tokyo, Japan). ECs were stained with TRITC–UEA 1 lec-
tin (Sigma-Aldrich) (diluted 1:1000) for 45 min in room 
temperature protected from light. MSCs were stained with 
mouse antihuman α-SMA (Santa Cruz Biotechnology, 
Santa Cruz, CA) diluted 1:200 in PBS/2% FBS, and with 
Alexa594-conjugated goat antimouse IgG secondary   
antibody diluted 1:3000. 4′,6-Diamidino-2-phenylindole 
(DAPI) staining was done in 1:3000 dilution for 2 min in 
room temperature.
Statistical analysis
Statistical evaluation of total tube length, total tube area, 
and total tube perimeter was acquired through the “tube 
formation” analysis module in AttoVision v1.6.1. Tube 
total length was defined as the total number of pixels com-
prising the network in the image field. Calculations of tube 
total area and perimeter treat a single particle as an aggre-
gate of square pixels, where a single-pixel segment has an 
area of 1 and a perimeter of 4, leading to consistent results 
across all scales of magnification. PCR data presented are 
from at least three parallel samples and were repeated with 
different stem cell donors to confirm consistency. SPSS 
Statistics 19.0 (IBM, Armonk, NY) was applied for statisti-
cal processing and analysis, and groups were compared 
with the independent samples t-test. The significance level 
was set to p < 0.05.
Results
Endothelial microvascular networks after 
coculture of ECs and bone marrow–derived 
MSCs
Development of capillary-like structures in EC/MSC cocul-
ture followed the same pattern as the EC/vSMC coculture,21 
with EC forming an interconnected network over a conflu-
ent layer of MSC (Figure 1(c)). In coculture, branching of 
EC happened within days, and a well-established network 
was observed at day 6 (Figure 1(a)). In monocultured EC, 
endothelial networks could not be observed at day 6 (Figure 
1(d)), with EC presenting cobblestone-like morphology 
(Figure 1(e)), illustrating the importance of supporting cells 
for EC in the process of network formation. At 3 days, 
mRNA expression of VEGFa was significantly upregulated 
in coculture compared to EC alone (p < 0.01), but also sig-
nificantly lower compared to the indirect culture system (p 
< 0.05) (Figure 1(f)).
Endothelial gene expression in coculture 
with bone marrow–derived MSCs
Gene expression of EC markers Ang1, Ang2, and vWF was 
evaluated at 3 days (Figure 2). mRNA expression of Ang1 
and vWF was significantly upregulated in coculture com-
pared to monoculture (p < 0.01), whereas expression of 
Ang2 was not significantly different in the two culture 
systems.4  Journal of Tissue Engineering 3(1)
Effect of osteogenic stimulatory medium 
on growth and maturation of endothelial 
microvascular networks
Quantitative measurements of total tube length in coculture 
showed the highest values under osteogenic stimulatory 
conditions (Figure 3(a)), indicating increased cell prolifera-
tion of EC during the initial phase. Analysis of total tube 
area and perimeter were performed to evaluate network 
maturation (Figure 3(b) and (c)), and at 3 days, both param-
eters were lower in OM compared to EGM. At 6 days, 
measurements were similar under both culture conditions 
and increasingly higher in OM until cocultures were fixed 
at 15 days (Table 2). A similar trend was observed in cocul-
tures where EGM medium was used for the first 7 days and 
osteogenic medium from days 7 to 15. An increase in total 
tube length as well as decreased total tube area and perim-
eter were seen after the change to osteogenic medium. At 
day 15, the EGM + OM networks were stable with a higher 
total length than the EGM group, but lower than the OM 
group, while the total tube area and perimeter surpassed the 
EGM group (Figure 3(a) to (c)). Endothelial microvascular 
networks developed in OM had the most elaborate inter-
connections and structures after 15 days (Figure 4), as well 
as significantly increased network growth and maturation 
(p < 0.01) (Figure 5).
Osteogenic stimulatory medium supports 
perivascular and osteogenic differentiation 
of MSCs
In order to address perivascular differentiation of MSC in 
osteogenic medium, gene expression of smooth muscle 
markers after 15 days of coculture was analyzed with real-
time RT-PCR. Relative expression of SM22-α and α-SMA 
was significantly higher (p < 0.01) in coculture compared 
to monoculture of MSC (Figure 6(a) and (b)). MSC posi-
tive for α-SMA were observed through histological stain-
ing (Figure 6(c)) and could be compared to the total number 
of MSC at 15 days culture in OM (Figure 6(d)). Extracellular 
Table 2.  Quantitative assessment of endothelial microvascular networks
3 days 6 days 12 days 15 days
Total tube length (pixels)
 EGM Mean 76,903 110,871 76,217 63,936
SD 21,807 37,000 22,337 14,332
 MC Mean 1942 29,629 38,141 25,522
SD 639 23,495 12,189 11,506
 OM Mean 89,719 200,287 136,547 108,389
SD 38,680 44,099 18,358 14,228
  EGM + OM Mean 76,900 110,870 117,420 94,210
SD 21,807 37,000 29,710 11,790
Total tube area (µm2)
 EGM Mean 359,761 281,606 282,345 297,982
SD 44,275 49,583 50,747 51,328
 MC Mean 117,142 138,190 86,915 75,141
SD 53,779 55,923 31,000 25,226
 OM Mean 168,686 288,537 343,105 417,791
SD 50,828 48,098 96,469 99,061
  EGM + OM Mean 359,761 281,606 192,308 313,728
SD 44,275 49,583 55,478 60,785
Total tube perimeter (µm)
 EGM Mean 31,824 31,619 32,920 35,584
SD 4246 6270 4044 5840
 MC Mean 16,996 18,362 12,095 10,165
SD 9407 6212 3607 2878
 OM Mean 21,736 36,516 40,377 41,813
SD 3846 5358 6350 5836
  EGM + OM Mean 31,824 31,619 28,139 40,629
SD 4246 6671 7918 6247
EGM: Endothelial Cell Growth Medium; MC: MesenCult; SD: standard deviation.Pedersen et al.  5
Figure 1.  Endothelial network establishment in coculture with bone marrow–derived MSCs. (a) The 2 × 2 montage image (10×) 
with live fluorescence microscopy from network of GFP-expressing EC cocultured with MSC. At 6 days, ECs have organized into 
stabilized networks. Scale bar = 100 µm. (b) UEA lectin staining of fixed GFP-expressing EC (20×) organized in elongated structures 
at 6 days. Scale bar = 50 µm. (c) DAPI staining (20×) showing the confluent layer of MSC supporting EC network formation at 6 
days. Scale bar = 50 µm. (d) Live fluorescence microscopy after 6 days of monocultured GFP-expressing EC (10×) that did not 
spontaneously organize into capillary-like networks. Scale bar = 100 µm. (e) Monocultured EC (20×) presented a cobblestone-like 
morphology. Scale bar = 50 µm. (f) EC expression of VEGFa was significantly upregulated in coculture at 3 days, but also significantly 
lower than in indirect culture with shared culture medium. *p < 0.05, **p < 0.01.
GFP: green fluorescent protein; EC: endothelial cell; MSC: mesenchymal stem cell; DAPI: 4′,6-diamidino-2-phenylindole; VEGF: vascular endothelial 
growth factor.6  Journal of Tissue Engineering 3(1)
matrix staining for collagen IV revealed abundant amounts 
surrounding endothelial tubes (Figure 6(e)). Production of 
basement membrane proteins indicates a mature vascular 
network, associated with arrested EC proliferation. Alizarin 
red S staining showed calcium deposition from differenti-
ated MSC (Figure 6(f)), illustrating the ability of the stem 
cell population to undergo both perivascular and osteogenic 
differentiation under the same culture conditions.
Discussion
A variety of culture systems have been used to investigate 
crosstalk between ECs and perivascular mural cells.23 In 
order to address vascular development through quantitative 
high-content imaging techniques, Evensen et al.21,24 adapted 
coculture of EC and vSMCs so as to enable high-through-
put screening of EC behavior. Limited information exists to 
date regarding the functional and molecular mechanisms 
behind vascular development under osteogenic stimulatory 
conditions. In the present study, we used coculture of EC 
and MSC with this novel in vitro angiogenesis screening 
method to investigate the development of endothelial 
microvascular networks under different culture conditions, 
in order to identify a system, which would optimize prevas-
cularization of tissue-engineered bone constructs.
EC recruitment of pericyte precursors and subsequent 
differentiation during vascular development was investi-
gated by Hirschi et al.,25 where smooth muscle markers, 
SM-myosin, SM22-α, and calponin, were expressed from 
precursor cells both in vitro and in vivo after coculture 
with EC. Au et al.12 found that in addition to expressing 
smooth muscle markers in vitro, MSC could support a 
lasting vasculature in vivo when provided with basement 
membrane proteins. MSCs have thus been identified as 
an appropriate cell type for investigating perivascular 
cell differentiation as well as vascular engineering. In the 
presence of MSC, EC spontaneously organized into elon-
gated interconnected structures, leading to establishment 
of endothelial microvascular networks after 3 days. 
Cellular interactions in coculture have been shown to 
result in the production of matrix proteins like fibronec-
tin and collagen I and a periendothelial matrix that leads 
to migratory and morphogenic EC.21 Such characteristics 
were not observed in monoculture in the present study, 
suggesting that EC may depend on perivascular cells for 
rapid network organization in vitro.
Several authors have discussed the role of Ang1 as a 
mediator of vascular maturation, recruiting perivascular 
cells and maintaining interactions between cells and the 
extracellular matrix.26–28 Vascular development is initi-
ated by VEGF-promoting proliferation, migration and 
sprouting of ECs,29,30 whereas establishment of functional 
vessels is facilitated by Ang1.31,32 Thurston et al.33 identi-
fied the role of Ang1 in promoting vessels resistant to 
leakage, compared to vessels solely induced by VEGF. 
Endothelial microvascular networks were morphologi-
cally obvious after 3 days in our study, and real-time 
RT-PCR analysis was performed in order to better under-
stand the underlying mechanisms on the molecular level. 
We found significantly higher expression of Ang1 from 
EC in coculture (p < 0.01).
In quiescent vasculature, expression of Ang2 is barely 
detectable, but significant upregulation can be observed 
during angiogenic sprouting.31 Angiopoietins 1 and 2 
both bind to the Tie2 receptor, and the role of Ang2 in 
vascular destabilization is mediated through competitive 
receptor binding with Ang1.31,34 The similar expression 
of Ang2 in both culture systems here indicates estab-
lished quiescent EC after 3 days, suggesting that the pro-
cess of network maturation involves interplay between 
angiopoietins 1 and 2, more specifically through upregu-
lation of Ang1.
Figure 2.  Endothelial gene expression in coculture at 3 days. Expression of (a) angiopoietin 1, (b) angiopoietin 2, and (c) von 
Willebrand factor in monoculture and coculture. **p < 0.01.
EC: endothelial cell; MSC: mesenchymal stem cell.Pedersen et al.  7
The function of VEGF and its receptors in vascular 
development and angiogenesis has been thoroughly inves-
tigated, and their regulatory function in the cardiovascular 
system was reviewed by Olsson et al.35 VEGF is required 
for development of EC networks in several angiogenesis 
assays, including coculture with vSMCs and when cul-
tured on a supporting matrix.21,36 In agreement with this, 
we found that expression of VEGF from EC was signifi-
cantly higher in the cocultures. Increased release of VEGF 
from MSC through paracrine signaling has previously 
been reported,37 and we report a similar finding of VEGF 
expression from EC where direct contact yielded signifi-
cantly lower mRNA compared to the indirect system (p < 
0.05). Both in embryonic development and in the forma-
tion of blood vessels in adults, it is evident that VEGF and 
Ang1 work together in a complementary fashion. Our data 
indicate a combined paracrine and direct contact commu-
nication also for tissue-engineered vessels.
vWF is a platelet adhesion mediator known for its 
essential role in hemostasis, but more recently it has been 
shown to have multiple roles in vascular development.38,39 
Enhancement of in vitro angiogenesis through a VEGF 
receptor 2 (VEGFR-2)–dependent pathway has been 
achieved through vWF inhibition and is associated with 
increased release of Ang2.39 The same authors also found 
increased VEGF-induced proliferation after vWF inhibi-
tion and attributed the effect to intracellular vWF. Our 
results suggest a role for vWF in EC stabilization, in that 
it is associated with loss of proliferation, and shows the 
interplay of VEGF and angiopoietins in formation of 
mature endothelial networks. Future studies are war-
ranted to explore the initial molecular mechanisms of 
endothelial organization in coculture beyond the require-
ment of VEGF.
Microvascular network formation occurs rapidly fol-
lowing osteogenic stimulation, with OM seeming to exert 
an initial proliferative effect on EC. β-Glycerophosphate is 
added to osteogenic medium to mediate mineral formation 
through hydrolysis by bone cells,40 whereas ascorbic acid 
(AA) is an important cofactor in the synthesis of collagen41 
and subsequently for the production of osteoid from MSC/
osteoblasts (collagen I) and a vascular basement membrane 
from EC (collagen IV). Proliferation of MSC is influenced 
by the concentration of AA in culture, with increasing cell 
proliferation at low concentrations.41 In addition to colla-
gen synthesis, AA is required for osteogenic differentiation 
of MSC in vitro through both enhanced expression of oste-
oblastic markers and mineralization.19 AA also affects EC, 
with Yue et al.42 reporting morphological changes and 
decreased cellular proliferation of retinal EC when cultured 
with 75 g/mL AA in vitro. ECs have the ability to take up 
AA intracellularly and resecrete it into the culture medium,43 
potentially affecting cocultured MSC. However, studying 
isolated effects in monocultures is not sufficient to draw 
conclusions in coculture systems that involve complex 
interplay between both cell types.
Dexamethasone is used to induce MSC proliferation and 
osteogenic differentiation, but has also been reported to 
preserve stem cell characteristics when administered in low 
dose,44 and to reduce total cell number in cultures of bone 
marrow stromal cells.45 Jaiswal et al.19 concluded that this 
paradoxical effect of dexamethasone could be attributed to 
dosage, duration as well as the stage of differentiation. 
Measurements of total tube length in the pure OM group 
were significantly increased compared to the EGM group 
after 3 days, and continued to be so throughout the 
Figure 3.  Growth and maturation of endothelial networks 
in four culture conditions. (a) Total tube length was increased 
in OM from establishment of networks at 3 days and for the 
remaining experimental period. For all groups, the length 
decreased as networks stabilized. (b) Total tube area was greater 
in networks generated in EGM at 3 days. At 6 days, networks 
generated in OM presented the greatest total tube area. 
Networks generated in EGM but maintained in OM after 7 days 
saw a decreased area after OM was added, followed by a steady 
increase. A similar tendency could be observed for (c) total tube 
perimeter. Results show that OM initially stimulates network 
proliferation, and subsequently promotes development of stable 
networks with higher length, area, and perimeter.
EGM: Endothelial Cell Growth Medium; MC: MesenCult.8  Journal of Tissue Engineering 3(1)
experimental period. Indeed, the same trend was seen in the 
EGM + OM group, where OM was introduced at day 7. 
This shows the ability of mature microvascular networks to 
react to stimulation with osteogenic medium, and reenter 
the proliferative phase. Network maturation parameters, 
however, were initially lower in OM, a trend also observed 
in the EGM + OM group. Lian and Stein46 determined that 
growth and differentiation are functionally related in a 
reciprocal manner, where arrested cell division is needed 
for differentiation. Delayed network maturation is therefore 
to be expected in the proliferative phase, and further meas-
urements of total tube area and perimeter in fact showed a 
linear increase surpassing the EGM group before stabiliz-
ing on a significantly higher level. By day 6, all three 
parameters were highest in OM suggesting that prevascu-
larization of 6 days or longer will benefit from osteogenic 
stimulatory conditions.
Plasticity of MSC is essential for providing perivas-
cular support and osteogenic differentiation within a 
tissue-engineered construct. Recruitment of pericytes, 
cells positive for α-SMA, is a critical step in vascular 
maturation in vivo, and strongly associated with a stable 
vascular plexus.10 SM22-α is a protein associated with 
the contractile apparatus of the cytoskeleton and 
restricted to the smooth muscle cell lineage,47 whereas 
α-SMA is a commonly used marker for the smooth mus-
cle phenotype and highly expressed in quiescent smooth 
muscle cells. α-SMA is not exclusively expressed in 
smooth muscle cells, and the findings of α-SMA in MSC 
are among increasing evidence that pericytes might be 
MSC residing in close proximity to the microvascula-
ture.48 Elevated gene expression of SM22-α and α-SMA 
from MSC when cocultured with EC shows the ability of 
MSC to take on a perivascular function in endothelial 
microvascular networks under osteogenic stimulatory 
conditions. Further maturation of these networks was 
demonstrated through extracellular matrix staining, 
showing tubes enveloped with collagen IV forming 
Figure 4.  Established endothelial networks after coculture in different culture media. The 2 × 2 montage live fluorescence 
microscopy of GFP-expressing EC (10×) under four culture conditions after 15 days. (a) EGM, (b) MC, (c) OM, and (d) EGM + OM. 
Seeded EC/MSC are the same for all four conditions. Scale bar = 100 µm.
EGM: Endothelial Cell Growth Medium; EC: endothelial cell; MC: MesenCult.Pedersen et al.  9
basement membrane-like structures, a crucial event in 
stabilizing newly formed vessels.8 Importantly, endothe-
lial tubes presented distinct lumens in a manner compa-
rable to a vascular plexus.
The EC as a mediator of osteogenic differentiation has 
received much attention,15,17 and ECs have been shown to 
enhance in vivo bone formation when cocultured with 
MSCs.22,49 We investigated if MSCs could serve a perivas-
cular function and differentiate into osteoblasts within the 
same culture system. Alizarin red S staining of calcium 
showed obvious positive staining in cocultures after 15 
days. This result is in agreement with Ma et al.18 who 
reported that a higher ratio of EC in coculture with MSC 
resulted in increased calcium deposition, concluding that 
both stimulation with osteogenic constituents and interac-
tions with EC were necessary for osteogenic differentia-
tion. It has been reported that coculture systems increase 
the life span and survival of ECs,50 a process possibly 
depending on the coculture ratio, where <50% ECs are 
reported as a prerequisite for survival in OM.18 The rela-
tively high initial percentage (80%) of MSC used in culture 
in the current study should be considered since we have 
shown that the MSC population has the ability for both 
perivascular and osteogenic differentiation. It remains to be 
determined whether the ECs or the osteogenic medium is 
the major contributing factor for mineralization in cocul-
ture at this ratio. The relative number of the cells in cocul-
ture systems is dynamic, where the percentage of EC has 
been shown to decrease over time.51 This supports the 
notion that MSC facilitates network maturation with subse-
quent reduced proliferation. The cell ratio used in the cur-
rent experiments might therefore not be as favorable in 
other culture conditions; nevertheless, data suggest the high 
percentage of MSC to be beneficial for endothelial micro-
vascular network development and for the dual function of 
MSC in OM.
Conclusion
Under coculture conditions, MSC supported the forma-
tion of stable and mature endothelial microvascular net-
works associated with upregulated expression of Ang1, 
VEGFa, and vWF. In cultures lasting longer than 6 days, 
OM enhanced growth and maturation of endothelial 
microvascular networks. In addition, OM had the ability 
to support perivascular and osteogenic differentiation of 
MSC. Future studies are warranted to evaluate vascular 
development in OM using artificial three-dimensional 
scaffolds, and our findings suggest that OM would be an 
excellent culture medium for prevascularization of bone 
implants.
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Figure 5.  Network evaluation parameters at 15 days. 
Quantifications of (a) total tube length, (b) total tube area, and 
(c) total tube perimeter after 15 days coculture in four different 
culture media. Statistical differences indicated are compared to 
coculture in EGM. * p < 0.05, **p < 0.01.
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